Option Care stock jumps 32.88% on takeover agreement
Option Care Health (OPCH) shares rose 32.88% to $31.055 after McKesson and Clayton Dubilier & Rice agreed to acquire the company for $32.05 per share, according to Seeking Alpha. The $5.8 billion deal has driven the stock above key technical levels, with the daily RSI14 at 83.76, indicating overbought conditions.
How this was made
The 30-second read
Why it matters
The announcement triggers a sharp price rally, with the stock trading near the offer price and likely to test the $32.05 level.
Market read
The deal is material for the healthcare sector and creates a short‑term trading opportunity on OPCH.
What to watch
Potential antitrust review and integration risk could delay closing and affect price.
Background
Option Care Health (OPCH) is a provider of home infusion services; the acquisition by McKesson and CD&R values the company at $5.8B including debt.
Ticker impact
Option Care Health announced a definitive acquisition agreement with McKesson and Clayton Dubilier & Rice at $32.05 per share, driving a 32.88% price jump.
likely upward pressure as traders price in the $32.05 offer
A large $5.8B takeover at a premium to the market typically fuels buying until the deal closes.
Market effects
Consolidation in the home infusion and specialty pharmacy sector may pressure peers.
U.S. healthcare services market sees increased M&A activity.
Limited to U.S. healthcare and specialty pharmacy investors.
Counterpoint
If the deal faces regulatory hurdles, the stock could fall sharply below current levels.
Key entities
- CompanyOption Care Health
Target of the acquisition.
- CompanyMcKesson
Acquirer in the deal.
- Private EquityClayton Dubilier & Rice
Co‑acquirer in the deal.
